Editas Medicine, Inc. (EDIT) Insider Trading
Over the last 3 months, EDIT insiders made 0 open-market buys and 5 sales, a net sale of -$60K (SEC Form 4). Over the last 6 months, 136 institutions increased and 95 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$59.7K
Insider trades by month Buys Sells
Sep
Dec
Mar
Jun
Jul
Aug
Context3-month price -7.5%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Ellinor Patrick Thomas IIdirector | Grant | 103,400 | $2.90 |
| Aug 5, 2026 | Parison Amyofficer: SVP, Chief Financial Officer | Sell | 678 | $2.58 |
| Jul 29, 2026 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $2.67 |
| Jun 22, 2026 | Levy Elliott M.director | Grant | 51,700 | $2.55 |
| Jun 22, 2026 | Hirsch Andrewdirector | Grant | 51,700 | $2.55 |
| Jun 22, 2026 | Hopfield Jessicadirector | Grant | 51,700 | $2.55 |
| Jun 22, 2026 | Scadden Daviddirector | Grant | 51,700 | $2.55 |
| Jun 22, 2026 | Connaughton Bernadettedirector | Grant | 51,700 | $2.55 |
| Jun 5, 2026 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 731 | $2.70 |
| Jun 5, 2026 | Parison Amyofficer: SVP, Chief Financial Officer | Sell | 464 | $2.70 |
| Jun 5, 2026 | O'Neill Gilmore Neildirector, officer: CEO | Sell | 15,380 | $2.70 |
| Mar 16, 2026 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Grant | 292,856 | $2.54 |
| Mar 16, 2026 | O'Neill Gilmore Neildirector, officer: CEO | Grant | 1,015,200 | $2.54 |
| Mar 16, 2026 | Parison Amyofficer: SVP, Chief Financial Officer | Grant | 292,856 | $2.54 |
| Mar 4, 2026 | O'Neill Gilmore Neildirector, officer: CEO | Sell | 5,394 | $2.02 |
| Mar 4, 2026 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 749 | $2.02 |
| Mar 4, 2026 | Parison Amyofficer: SVP, Chief Financial Officer | Sell | 474 | $2.02 |
| Dec 4, 2025 | Parison Amyofficer: SVP, Chief Financial Officer | Sell | 461 | $2.15 |
| Dec 4, 2025 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $2.15 |
| Dec 4, 2025 | O'Neill Gilmore Neildirector, officer: CEO | Sell | 5,603 | $2.15 |
| Sep 4, 2025 | O'Neill Gilmore Neildirector, officer: CEO | Sell | 5,592 | $2.60 |
| Sep 4, 2025 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $2.60 |
| Sep 4, 2025 | Parison Amyofficer: SVP, Chief Financial Officer | Sell | 458 | $2.60 |
| Aug 8, 2025 | Parison Amyofficer: SVP, Chief Financial Officer | Sell | 679 | $2.58 |
| Aug 4, 2025 | Burkly Lindaofficer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $2.49 |
| Jun 10, 2025 | Connaughton Bernadettedirector | Grant | 37,500 | $1.91 |
| Jun 10, 2025 | Hopfield Jessicadirector | Grant | 37,500 | $1.91 |
| Jun 10, 2025 | Hirsch Andrewdirector | Grant | 37,500 | $1.91 |
| Jun 10, 2025 | Levy Elliott M.director | Grant | 37,500 | $1.91 |
| Jun 10, 2025 | Scadden Daviddirector | Grant | 37,500 | $1.91 |
Source: EDIT SEC Form 4 filings, latest Aug 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their EDIT positions over the last 6 months (SEC Form 13F).
Increased
136
New positions
77
Reduced
95
Sold out
24
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| TCG Crossover Management, LLC | New Position | 11.1M | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 10.6M | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 9.3M | May 13, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | New Position | 8.9M | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | New Position | 8.9M | Aug 14, 2026 |
| Commodore Capital LP | New Position | 8.9M | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6.1M | Aug 13, 2026 |
| Paradigm Biocapital Advisors LP | New Position | 5.6M | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.2M | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 4.0M | May 14, 2026 |
| Opaleye Management Inc. | Increased | 3.9M | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 3.6M | Aug 13, 2026 |
| Woodline Partners LP | New Position | 3.6M | Aug 14, 2026 |
| Vivo Capital, LLC | New Position | 3.6M | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 3.1M | May 8, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.